신생아 집중치료실에서 극단 저체중 미숙아의 동맥관 개존증 폐쇄술을 위한 remifentanil과 sevoflurane의 사용 경험 -증례 보고-
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 이희종 | - |
dc.contributor.author | 정미애 | - |
dc.contributor.author | 최진화 | - |
dc.contributor.author | 조주원 | - |
dc.date.accessioned | 2022-12-20T16:36:58Z | - |
dc.date.available | 2022-12-20T16:36:58Z | - |
dc.date.created | 2022-09-19 | - |
dc.date.issued | 2010-06 | - |
dc.identifier.issn | 1975-5171 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/174530 | - |
dc.description.abstract | Surgical ligation of PDA is an effective treatment for symptomatic infants who do not respond to treatment with indomethacin. Transfer of unstable infants to the operating room has been shown to be associated with various problems. Thus, we describe the anesthetic management of 5 extremely low birth weight (ELBW) infants who underwent surgical ligation of PDA in a neonatal intensive care unit (NICU). General anesthesia was induced by ketamine 1 mg/kg IV. Rocuronium was used for muscle relaxation. Anesthesia was maintained with continuous infusion of remifentanil 0.15−0.4 ug/kg/min with oxygen (in 2 cases) or continuous infusion of remifentanil 0.05−0.1 ug/kg/min and 0.4−1.0 vol% sevoflurane with oxygen (in 3 cases). It was safe and effective to perform bedside PDA ligation in the NICU. We describe the successful use of remifentanil with sevoflurane or remifentanil alone in 5 extremely low birth weight infants undergoing PDA ligation. | - |
dc.language | 한국어 | - |
dc.language.iso | ko | - |
dc.publisher | 대한마취통증의학회 | - |
dc.title | 신생아 집중치료실에서 극단 저체중 미숙아의 동맥관 개존증 폐쇄술을 위한 remifentanil과 sevoflurane의 사용 경험 -증례 보고- | - |
dc.title.alternative | Experience with remifentanil/remifentanil - sevoflurane anesthesia for surgical ligation of patent ductus arteriosus (PDA) in premature infants in the neonatal intensive care unit−A case report− | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | 정미애 | - |
dc.identifier.bibliographicCitation | Anesthesia and Pain Medicine, v.5, no.4, pp.347 - 350 | - |
dc.relation.isPartOf | Anesthesia and Pain Medicine | - |
dc.citation.title | Anesthesia and Pain Medicine | - |
dc.citation.volume | 5 | - |
dc.citation.number | 4 | - |
dc.citation.startPage | 347 | - |
dc.citation.endPage | 350 | - |
dc.type.rims | ART | - |
dc.identifier.kciid | ART001489641 | - |
dc.description.journalClass | 2 | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | kci | - |
dc.description.journalRegisteredClass | other | - |
dc.subject.keywordAuthor | Intensive care unit | - |
dc.subject.keywordAuthor | Patent ductus arteriosus | - |
dc.subject.keywordAuthor | Premature | - |
dc.subject.keywordAuthor | Remifentanil | - |
dc.subject.keywordAuthor | Sevoflurane. | - |
dc.identifier.url | http://www.riss.kr/search/detail/DetailView.do?p_mat_type=1a0202e37d52c72d&control_no=b5e64a4f34750df6b7998d826d417196 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365
COPYRIGHT © 2021 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.